首页 | 本学科首页   官方微博 | 高级检索  
检索        

NP方案与TP方案治疗晚期非小细胞肺癌的临床研究
引用本文:侯恩存,张海燕.NP方案与TP方案治疗晚期非小细胞肺癌的临床研究[J].重庆医学,2009,38(3).
作者姓名:侯恩存  张海燕
作者单位:1. 广西中医学院附属瑞康医院肿瘤科,南宁,530011
2. 山东省菏泽医学专科学校,山东菏泽,274000
摘    要:目的 探讨NP方案和TP方案对初治的晚期非小细胞肺癌(NSCLC)的疗效和不良反应.方法 80例晚期NSCLC患者随机分成NP组和TP组,入组的每例患者均接受至少2个周期以上同方案的化疗,比较两组不同化疗方案的近期疗效和不良反应.结果 NP和TP两组近期疗效的有效率分别为42.5%和55.0%,两组资料差异无统计学意义.不良反应方面,两组以骨髓抑制和消化道反应为主,均在可耐受的范围内,NP组静脉炎发生率较高.结论 NP和TP两种化疗方案对晚期NSCLC均有较好的临床疗效,化疗不良反应虽有所不同,但可耐受.因此NP和TP两种化疗方案均可作为晚期NSCLC的一线治疗方案,但TP方案在疗效和不良反应方面更有优势.

关 键 词:非小细胞肺癌  化疗  长春瑞滨  紫杉醇  顺铂

Clinical study of original chemotherapy for advanced non-small cell lung cancer with NP regimen and TP regimen
HOU En-cun,ZHANG Hai-yan.Clinical study of original chemotherapy for advanced non-small cell lung cancer with NP regimen and TP regimen[J].Chongqing Medical Journal,2009,38(3).
Authors:HOU En-cun  ZHANG Hai-yan
Institution:HOU En-cun1,ZHANG Hai-yan2(1.Department of Oncology,Ruikang Hospital of Guangxi TCM College,Nanning 530011,China,2.Heze Medical College,Heze,Sh,ong 274000,China)
Abstract:Objective To investigate the efficacy and toxicity of the NP regimen and TP regimen on advanced non-small cell lung cancer.Methods Eighty patients with advanced non-small cell lung cancer were divided into the NP group and the TP group randomly.All the patients had accepted intravenous chemotherapy and preponderated over 2 cycles.Then to study the short term effectiveness and adverse effects.Results The short term effective rate for advanced non-small cell lung cancer in NP group and TP group was 42.5% and ...
Keywords:non-small cell lung cancer  chemotherapy  navelbine  paclitaxel  cisplatin  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号